Genscript Biotech (HK:1548) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Genscript Biotech has appointed Dr. John Anthony Quelch as an independent non-executive director and member of its strategy committee, effective November 14, 2024. Dr. Quelch brings a wealth of experience in global strategy and corporate governance, having held leadership roles in prestigious business schools and serving as a director for various publicly listed companies. This strategic move is expected to enhance Genscript’s governance and strategic planning.
For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.
